*Disseminated on Behalf of Nexalin Technology, Inc. Please see disclosures below. |
| 5 Reasons to Look Into Nexalin |
| | | | | Folks,
Here's why you should pay attention to Nexalin Technology (NXL):
1. $60 billion+ addressable market across insomnia, anxiety, depression, Alzheimer's, and TBI/PTSD. 2. Already approved in four countries — China, Brazil, Oman, and Israel — generating near-term revenue while pursuing FDA clearance. 3. Two-device strategy — the Gen 2 SYNC targets clinics ($25-40K per unit) while the Gen 3 HALO brings treatment into the home with a subscription model ($30-50/month). 4. Growing patent portfolio with 7 patents issued through 2036 and 21 pending across 14+ countries. 5. Military advisory board featuring General Wesley Clark and representatives from the Department of Defense and Veterans Affairs — positioning for the massive TBI/PTSD opportunity.
Anyways...
That's all for now!
Until Next Time,
-ZT Team | P.S. Want our text alerts? Text "ZIPTRADER" to 1-(855)-228-1598 to sign up!
(standard carrier data/text rates apply) |
|
|
|---|
|
*Disseminated on Behalf of Nexalin Technology, Inc. Please see disclosures below. |
|
|---|
|
| | 5101 SANTA MONICA BLVD STE 8 #62, 90029, LOS ANGELES, CA |
| You've received it because you've subscribed to our newsletter or are a member of ZipTraderU. |
| This email was sent to stevenmagallanes520.nims@blogger.com |
| *SPONSORED CONTENT* ZipTrader LLC is a publishing company, we are not financial advisors. This is not financial advice. Investments involve risk and are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance. ZipTrader has been compensated thirty-four thousand USD by ACH Bank Transfer by TD Media LLC to distribute media via email, SMS, and YouTube on behalf of Nexalin Technology, Inc. (NXL) from February 4, 2026 to February 5, 2026. ZipTrader may receive additional campaigns in the future by TD Media LLC to distribute media for Nexalin Technology, Inc. (NXL). As a result of this advertisement and other marketing efforts, ZipTrader may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of ZipTrader do not hold a position in Nexalin Technology, Inc. (NXL). This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Nexalin Technology, Inc. (NXL), increased trading volume, and possibly an increased share price of Nexalin Technology, Inc. (NXL), which may or may not be temporary and decrease once the marketing arrangement has ended. |
| BY READING THIS EMAIL & ALL ZIPTRADER CONTENT YOU AGREE: This is not financial advice. You must do your own due diligence on all information. ZIPTRADER LLC is a publishing company and we provide general information, opinions, & news coverage to viewers. However – we do not provide personalized financial advice, are not financial advisors, and our opinions are not suitable for all investors. You should not treat any opinion as expressed as a specific inducement to make a particular investment or follow a particular strategy, but just as an opinion. Use at your own risk. Past Performance is not indicative of future results, and any results presented are not typical, and should not be understood as typical. Actual results vary given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. TRADING IS RISKY: Most traders in all markets lose all of their money (and more if they use margin). Most small businesses fail. Do NOT partake in trading, investing, entrepreneurship or any other risky endeavor covered here if you are not prepared with the reality that most fail. We reserve the right to have affiliate relationships with advertisers/sponsors. See Full Terms of Service. See Our Advertisement Disclaimer. |
| | |
|
|
|---|
|
|
|
No comments:
Post a Comment